Search Results - "Doehn, C"

Refine Results
  1. 1

    Aktualisierte S3-Leitlinie Nierenzellkarzinom by Doehn, C, Bergmann, L, Decker, J, Gauler, T, Grünwald, V, Weikert, St, Krege, S

    Published in Urologe. Ausgabe A (01-05-2024)
    “…HintergrundDas Nierenzellkarzinom (NCC) ist der dritthäufigste maligne Tumor unter den urologischen Tumoren. In Deutschland erkranken mehr als 14.000 Menschen…”
    Get full text
    Journal Article
  2. 2

    Deutscher Expertenkonsens zur PD-L1-Testung („programmed cell death ligand 1“) in der perioperativen Systemtherapie des muskelinvasiven Blasenkarzinoms by Niegisch, G, Bolenz, C, Doehn, C, Gakis, G, Hartmann, A, Müller-Huesmann, H, Reis, H, Roghmann, F, Schwamborn, K, Tiemann, K, Retz, M

    Published in Urologe. Ausgabe A (01-10-2024)
    “…Das Rezidivrisiko von Patienten mit einem muskelinvasiven Harnblasenkarzinom (MIBC) nach radikaler Zystektomie ist abhängig vom pathologischen Tumorstadium…”
    Get full text
    Journal Article
  3. 3

    Inhibition of bcl-2 Enhances the Efficacy of Chemotherapy in Renal Cell Carcinoma by Kausch, I., Jiang, H., Thode, B., Doehn, C., Krüger, S., Jocham, D.

    Published in European urology (01-05-2005)
    “…Renal cell cancer (RCC) is highly resistant to chemotherapy. Increased expression of the antiapoptotic gene bcl-2 in tumors is known to be associated with poor…”
    Get full text
    Journal Article
  4. 4

    Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer by Neumann, A, Keller, T, Jocham, D, Doehn, C

    Published in Aktuelle Urologie (01-09-2011)
    “…Testicular cancer is the most frequent cancer in patients between 20 and 40 years of age. Cure rates are very high due to standardised operative treatment as…”
    Get more information
    Journal Article
  5. 5

    New drugs for metastatic kidney cancer by Doehn, C

    Published in Aktuelle Urologie (01-01-2008)
    “…Systemic therapy of metastatic kidney cancer has undergone dramatic changes over the past years. One reason for this is our increasing knowledge of different…”
    Get more information
    Journal Article
  6. 6

    Whose Transplant Function Fails After Ureteral Revision Following Kidney Transplantation? by Doehn, C, Böse, N, Meyer, A, Jocham, D

    Published in Transplantation proceedings (01-06-2010)
    “…Abstract Background Kidney transplantation is associated with ureteral complications in about 5% of cases. While many reasons for ureteral complications are…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma by Miller, K, Bergmann, L, Doehn, C, Grünwald, V, Gschwend, J, Kuczyk, M

    Published in Aktuelle Urologie (01-03-2015)
    “…Patients with metastatic renal cell carcinoma have a life-limiting prognosis. Therefore, the aim of therapy is normally palliative care. Nevertheless,…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Laparoscopic Versus Open Bilateral Nephrectomy in Transplant Recipients With Medication-Resistant Hypertension: Final Results of a Multicenter Study With 15 Years of Follow-up by Wagner, S, Greco, F, Doehn, C, Hoda, M.R, Girndt, M, Jocham, D, Fornara, P

    Published in Transplantation proceedings (01-09-2011)
    “…Abstract Background The objective of this study was to evaluate the outcomes of laparoscopic bilateral nephrectomy (LBN) compared with open bilateral…”
    Get full text
    Journal Article
  11. 11

    Active surveillance for renal cell carcinoma by Doehn, C, Witzsch, U, Siebels, M

    Published in Aktuelle Urologie (01-07-2012)
    “…The incidence of renal cell carcinoma (RCC) and especially that of small RCCs is increasing. However, not all tumours are malignant and not all malignant…”
    Get more information
    Journal Article
  12. 12

    How accurate is the correlation between clinical and pathological TNM stages in renal tumours? by Frommhold, J, Jocham, D, Doehn, C

    Published in Aktuelle Urologie (01-07-2011)
    “…In clinical practice the tumour size measured in the histopathological examination of the operative specimen is used both to determine tumour stage. We have…”
    Get more information
    Journal Article
  13. 13

    Urinary bladder cancer in Wegener’s granulomatosis: is it more than cyclophosphamide? by Hellmich, B, Kausch, I, Doehn, C, Jocham, D, Holl-Ulrich, K, Gross, W L

    Published in Annals of the rheumatic diseases (01-10-2004)
    “…[...]several molecular tests which are based on urine analysis have yielded promising results and are beginning to be established in clinical diagnosis and…”
    Get full text
    Journal Article
  14. 14

    Ureteropelvic junction obstruction with renal hypertension by Kazarians, B, Cordes, J, Jocham, D, Doehn, C

    Published in Aktuelle Urologie (01-05-2011)
    “…Renal hypertension can occur with unilateral ureteropelvic junction obstruction and consecutive hydronephrosis. It is rarely the main symptom, normally in…”
    Get more information
    Journal Article
  15. 15

    Follow-up of renal cell carcinoma based on stage and initial treatment by Doehn, C, Siebels, M, Steiner, T

    Published in Urologe. Ausgabe A (01-02-2020)
    “…Renal cell carcinoma is the third most common tumor of the genitourinary system. Small tumors are increasingly treated by nephron-sparing surgery, focal…”
    Get full text
    Journal Article
  16. 16

    Immunotherapy and tyrosine kinase inhibitors in first-line treatment of metastatic renal cell carcinoma-Which strategy when? by Mickisch, G, Peters, I, Grüllich, C, Mudra, T, Doehn, C

    Published in Urologe. Ausgabe A (01-12-2020)
    “…Immunotherapies with checkpoint inhibitors have led to a paradigm shift in metastatic renal cell carcinoma (mRCC) as they established a new standard in…”
    Get full text
    Journal Article
  17. 17

    Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma by Eisenhardt, A, Ohlmann, C-H, Doehn, C

    Published in Urologe. Ausgabe A (01-05-2020)
    “…Systemic therapy in uro-oncology is currently undergoing major changes. In the past, drug therapies only showed good treatment results in metastasized…”
    Get full text
    Journal Article
  18. 18

    Adjuvante Therapiestrategien beim Nierenzellkarzinom by Doehn, C.

    Published in Der Onkologe (01-10-2008)
    “…Zusammenfassung Das Nierenzellkarzinom hat unter den urologischen Tumoren die schlechteste Prognose. Meist besteht die Primärtherapie in seiner operativen…”
    Get full text
    Journal Article
  19. 19

    Causes and course of fornix rupture by Doehn, C, Fiola, L, Peter, M, Jocham, D

    Published in Aktuelle Urologie (01-03-2010)
    “…Fornix rupture is a urological emergency situation. In most cases ureteral stones represent the underlying cause. We present the largest series ever reported…”
    Get more information
    Journal Article
  20. 20